MREO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Mereo BioPharma Group PLC ADR

NASDAQ | MREO

1.84

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 26, 2025)

$292.80M

Market Cap

-

P/E Ratio

-0.26

EPS

$3.94

52 Week High

$1.47

52 Week Low

HEALTHCARE

Sector

MREO Chart

Recent Chart
Price Action

MREO Technicals

Tags:

MREO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$47M
Selling General And Administrative $26M
Research And Development $21M
Operating Expenses $47M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $3M
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$43M
Income Tax Expense $18K
Interest And Debt Expense -
Net Income From Continuing Operations -$43M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$43M

Revenue & Profitability

Earnings Performance

MREO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $76M
Total Current Assets $75M
Cash And Cash Equivalents At Carrying Value $70M
Cash And Short Term Investments $70M
Inventory -
Current Net Receivables $3.3M
Total Non Current Assets $1.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $643K
Intangible Assets Excluding Goodwill $643K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.7M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $14M
Current Accounts Payable $2.4M
Deferred Revenue -
Current Debt -
Short Term Debt $6.2M
Total Non Current Liabilities $1.6M
Capital Lease Obligations $894K
Long Term Debt -
Current Long Term Debt $5.5M
Long Term Debt Noncurrent -
Short Long Term Debt Total $6.4M
Other Current Liabilities $4.4M
Other Non Current Liabilities $565K
Total Shareholder Equity $61M
Treasury Stock -
Retained Earnings -$463M
Common Stock $3.1M
Common Stock Shares Outstanding $148M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$33M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.1M
Capital Expenditures $699K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$699K
Cashflow From Financing $46M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$43M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$1.1M
Total Revenue $0
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$47M
Selling General And Administrative $26M
Research And Development $21M
Operating Expenses $47M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $3M
Interest Expense $1.4M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.1M
Income Before Tax -$43M
Income Tax Expense $18K
Interest And Debt Expense -
Net Income From Continuing Operations -$43M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$41M
Net Income -$43M

MREO News

MREO Profile

Mereo BioPharma Group PLC ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Mereo BioPharma Group PLC is a London-based biopharmaceutical company committed to developing innovative therapies for oncology and rare diseases. With a robust pipeline focused on addressing significant unmet medical needs, Mereo employs its clinical development expertise to enhance patient outcomes through targeted treatments. The company's strategic positioning within the biopharmaceutical sector, combined with its diverse portfolio, underscores its potential for sustainable growth in both UK and international markets, appealing to institutional investors seeking opportunities in transformative healthcare solutions.

LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+117.39%
$1.06
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
TSLA
+1.71%
$426.58
CIFR
+9.30%
$19.15
SOFI
+0.56%
$28.49
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
KVUE
+1.11%
$17.22
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
DNN
+3.64%
$2.56
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
AMZN
-0.22%
$229.16
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
BMNU
+18.42%
$7.52
RIG
+6.17%
$4.30
RIVN
+3.98%
$16.18
PW
+18.87%
$0.99
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
IVP
-20.80%
$0.13
BBD
+3.95%
$3.68
AGNC
+1.53%
$10.56
CETY
-11.20%
$2.06
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
KALA
+42.62%
$0.91
CCL
-1.12%
$25.43
BULL
+6.43%
$9.26
SNAP
-0.39%
$7.61
GOOG
-1.03%
$320.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
AVGO
+3.25%
$397.57
WLGS
-5.57%
$0.04
VALE
+2.62%
$12.51
ABEV
0.00%
$2.51
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
PLTD
-1.37%
$7.16
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ORCL
+4.02%
$204.96
UPWK
-0.55%
$19.58
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
PCG
+1.78%
$16.01
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
CMG
+1.88%
$34.03
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
CAN
+0.75%
$0.92
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+117.39%
$1.06
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
AAL
+3.49%
$13.93
TSLA
+1.71%
$426.58
CIFR
+9.30%
$19.15
SOFI
+0.56%
$28.49
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
KVUE
+1.11%
$17.22
F
+0.15%
$13.19
AMD
+3.93%
$214.24
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
DNN
+3.64%
$2.56
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
AMZN
-0.22%
$229.16
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
BMNU
+18.42%
$7.52
RIG
+6.17%
$4.30
RIVN
+3.98%
$16.18
PW
+18.87%
$0.99
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
IVP
-20.80%
$0.13
BBD
+3.95%
$3.68
AGNC
+1.53%
$10.56
CETY
-11.20%
$2.06
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
KALA
+42.62%
$0.91
CCL
-1.12%
$25.43
BULL
+6.43%
$9.26
SNAP
-0.39%
$7.61
GOOG
-1.03%
$320.28
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
AVGO
+3.25%
$397.57
WLGS
-5.57%
$0.04
VALE
+2.62%
$12.51
ABEV
0.00%
$2.51
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
PLTD
-1.37%
$7.16
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
ORCL
+4.02%
$204.96
UPWK
-0.55%
$19.58
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
DVLT
-3.61%
$2.13
PCG
+1.78%
$16.01
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
CMG
+1.88%
$34.03
AFMD
-34.94%
$0.18
KOS
-1.83%
$1.07
HBI
-0.45%
$6.59
CAN
+0.75%
$0.92
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.